Rapt therapeutics, inc. (RAPT)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Dec'18
Assets
Current assets:
Cash and cash equivalents

91,529

77,383

48,310

63,798

Accounts receivable

5,010

-

-

-

Marketable securities

46,670

-

-

-

Prepaid expenses and other current assets

3,685

3,123

2,914

1,264

Total current assets

146,894

80,506

51,224

65,062

Property and equipment, net

3,606

3,707

4,002

4,159

Other assets

389

389

3,143

389

Total assets

150,889

84,602

58,369

69,610

Liabilities and stockholders' equity
Current liabilities:
Accounts payable

3,409

1,143

1,590

1,771

Accrued expenses

3,832

3,642

3,410

2,488

Deferred revenue, current

5,765

4,000

-

-

Other current liabilities

436

471

457

384

Total current liabilities

13,442

9,256

5,457

4,643

Deferred rent, net of current portion

2,218

2,225

2,219

969

Deferred revenue, non-current

3,300

-

-

-

Convertible preferred stock, $0.0001 par value: no shares and 104,018,468 shares authorized at December 31, 2019 and 2018, respectively; no shares and 16,415,281 shares issued and outstanding at December 31, 2019 and 2018, respectively

-

-

175,490

161,111

Stockholders' equity:
Common stock

2

2

1

1

Additional paid-in capital

307,009

235,049

23,923

22,441

Related party promissory note for the purchase of common stock

-

-

-

598

Accumulated other comprehensive income

7

20

13

-4

Accumulated deficit

-175,089

-161,950

-148,734

-118,953

Total stockholders' equity

131,929

73,121

-124,797

-97,113

Total liabilities and stockholders' equity

150,889

84,602

58,369

69,610